Finding a probable culprit can sometimes happen fairly quickly when something new pops up in the infectious diseases sphere. But that doesn't mean the end of the mystery. I n early April, when word began to circulate that hospitals in the United Kingdom were seeing unexplained hepatitis cases in very young children, some physicians and researchers on this side of the Atlantic experienced a moment of déjà vu. Kevin Messacar and colleagues at Children’s Hospital Colorado found themselves remarking on how reminiscent the unfolding investigation was of a medical mystery they’ve been enmeshed in for the past eight years — acute flaccid myelitis, or AFM, a polio-like condition in children. Meanwhile, Carlos Pardo, the co-principal investigator of a National Institutes of Health study into the natural history of AFM, started fielding queries from hepatologists at Johns Hopkins Medicine, where he teaches, about what kinds of samples they should be collecting from suspected hepatitis cases. “There are many parallels between this initial investigation of these cases of hepatitis of unknown origin and our initial investigations of AFM cases,” Messacar, a pediatric infectious disease physician and an associate professor at the University of Colorado, told STAT. As public health agencies race to figure out what is behind the unusual hepatitis cases, Messacar, Pardo, and others believe there are lessons to be learned from the ongoing efforts to solve the mysteries of AFM.
Chief among them is that getting to satisfactory answers is likely going to take time. There may be an answer to the fundamental question of what is causing these illnesses. But the whys and the how — Why now? Why only some children? Why these children? How is the damage being done? — may take considerably longer to resolve. “I think it could be a very difficult nut to crack,” said Michael Osterholm, director of the University of Minnesota’s Center for Infectious Diseases Research and Policy. Finding a probable culprit can sometimes happen fairly quickly when something new pops up in the infectious diseases sphere, said Thomas Clark, deputy director of the division of viral diseases at the Centers for Disease Control and Prevention. Clark was the CDC’s incident manager for the AFM investigation in 2018-2019. Such was the case when scientists started investigating AFM, which first pinged on the medical world’s radar in 2012, after California reported a few cases of unexplained paralysis among children. Suspicion soon focused on EV-D68, a member of the enterovirus family that is now generally assumed to be the primary cause of AFM. (Another enterovirus, A71, is also thought to trigger the condition in some cases.) AFM cases occur in very low numbers year round, but have been seen to cluster in every-other-year surges that occurred in 2014, 2016, and 2018. Where in an odd year there may be two or three dozen cases, there were 153 cases and 239 cases in 2016 and 2018, respectively. (Like many other viral illnesses, AFM has been driven to very low levels during the first two years of the Covid-19 pandemic, with an expected spike of cases failing to materialize in 2020.)
Settling on a suspect seems to have happened even faster with the unexplained cases of pediatric hepatitis, with many researchers hypothesizing that an adenovirus might be to blame. In the cases, previously healthy children, many under the age of 5, develop severe liver inflammation. Some — about 14% of the cases reported so far in the United States and 10% of those reported in the U.K. — have required liver transplants and a few children have died. The first observed cases occurred last October in Alabama, where five of the state’s eventual nine cases tested positive for an adenovirus. Like enteroviruses, the adenovirus family is large, encompassing about 50 types that infect people. Most cause cold-like illnesses, but a couple are known to infect the gastrointestinal tract. The one spotted by the Alabama physicians was one of the latter, type 41. A substantial portion — though not all — of the roughly 450 cases reported worldwide at this point have tested positive for adenovirus, and in the U.K., more in-depth testing has revealed at least some of those were adenovirus type 41. It remains unclear if this is an incidental finding unrelated to the hepatitis, or if the virus is causing the condition. Investigators are also exploring the question of whether there is some other contributing factor, such as the possibility that two years of pandemic-induced masking and social distancing may have left children’s immune systems inexperienced in fighting off an infection like this one. Another theory is that current or prior Covid-19 infection is amplifying the illness induced by adenovirus infection. As of yet, testing of liver biopsies taken from a number of the suspected cases and from failed livers that were removed from the children who needed transplants has not shown signs of adenovirus infection. Fingering a culprit, though, is only the first step in getting to the bottom of why a small but unusual number of very young children are ending up in hospital with their livers under attack. “It is often true, I guess, that the most commonly implicated virus or the one that’s putatively identified ends up explaining the illness,” said the CDC’s Clark. “But the mechanisms and the why are the challenge to figure out.” Scientists are still working to explain why EV-D68 causes paralysis as well as why it only does so in a tiny fraction of the children it infects.....